RCUS 1M 7.4% Increase and then 77% Decline

Viés de baixa

Arcus Biosciences, Inc. (NYSE:RCUS)

Atualizado

NYSE:RCUS Arcus Biosciences, Inc.

Trend Analysis Beyond Technical Analysis

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Comentário:

Measured move to $12.18 by Nov 2023

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.